Report #2839761

Received May 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: Apr 29, 2025
Onset: Apr 30, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (2)

Abdominal discomfortBack pain

Symptom narrative

abdominal discomfort; sore back; This non-serious case was reported by a consumer via sales rep and described the occurrence of abdominal discomfort in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 29-APR-2025, the patient received the 2nd dose of Shingrix (unknown arm). On 30-APR-2025, 1 days after receiving Shingrix, the patient experienced abdominal discomfort (Verbatim: abdominal discomfort) and sore back (Verbatim: sore back). The outcome of the abdominal discomfort and sore back were resolving. It was unknown if the reporter considered the abdominal discomfort and sore back to be related to Shingrix. It was unknown if the company considered the abdominal discomfort and sore back to be related to Shingrix. Additional Information: GSK Receipt Date: 30-APR-2025 The patient received subsequent dose of Shingrix. The patient experienced abdominal discomfort and sore back.